S-100 and NSE as serum markers in melanoma

Acta Oncologica

Volumn 36, Issue 7, 1997, Pages 761-764

  Tofani, Anna ^a   Cioffi, Raffaele P ^a   Sciuto, Rosa ^a   Rea, Sandra ^a   Festa, Anna ^a   Di Filippo, Franco ^a   Cavaliere, Renato ^a   Maini, Carlo L ^a,b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b La Pietra Pizzuta   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEURON SPECIFIC ENOLASE; PROTEIN S 100;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0031407773     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869709001351     Document Type: Article

References (27)

1. Paus H, Nuslad K. Immunoradiometric assay for αγ and γγ-enolase (neuron-specific enolase) with use of monoclonal antibodies and magnetizable polymer particles. Clin Chem 1989; 35: 2034-8.
2. Wibe E, Paus E, Aamdal S. Neuron-specific enolase (NSE) in serum of patients with malignant melanoma. Cancer Lett 1990; 52: 29-31.
3. Fagnart OC, Sindic CJM, Laterre C. Particle counting immunoassay of S100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system. Clin Chem 1988; 38: 1387-91.
4. Cooper EK. Neuron-specific enolase. Int J Biol Markers 1994; 9: 205-10.
5. Schmechel D, Marangos PM, Brightman M. Neuron-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature 1978; 276: 834-6.
6. Schaarschmidt H, Prange HW, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular disease. Stroke 1994; 24: 558-65.
7. Skogseid IM, Nordby HK, Urdal P, Paus E, Lilleaas F. Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage. Acta Neurochir 1992; 115: 106-11.
8. Isobe T, Ishioka N, Okuyama T. Structural relation of two S-100 proteins in bovine brain: subunit composition of S-100a protein. Eur J Biochem 1981; 115: 469-74.
9. Ludwin SK, Kosek JC, Eng LF. The topographic distribution of S-100 and GFA proteins in the adult rat brain: an immunohistochemical study using horseradish peroxidase-labelled antibodies. J Comp Neurol 1976; 165: 197-208.
10. Donato R. Perspectives in S-100 protein biology. Cell Calcium 1991; 12: 713-26.
11. Albert KA, Wu WC-S, Naim AC, Greengard P. Inhibition by calmodulin of calcium phospholipid dependent protein phosphorylation. Proc Natl Acad Sci USA 1984; 81: 3622-5.
12. Endo T, Hidaka H. Effects of S-100 protein on microtubule assembly disassembly. FEBS Lett 1983; 161: 235-8.
13. Shushoua VE, Hesse GW, Moore BW. Proteins of the brain extracellular fluid: evidence for release of S-100 protein. J Neurochem 1984; 42: 1536-41.
14. Whitaker-Azmitia PM, Murphy R, Azmitia EC. Stimulation of astroglial 5-HT receptor releases the serotoninergic growth factor, protein S-100 and alters astroglial morphology. Brain Res 1990; 528: 155-8.
15. Selinfreund RH, Barger SW, Pledger WJ, Van Eldik IJ. Neurotrophic protein S-100β stimulates glial cell proliferation. Proc Natl Acad Sci USA 1991; 88: 3554-8.
16. Cocchia D, Michetti F, Donato R. Immunohistochemical and immunocytochemical localization of S-100 antigen in normal human skin. Nature 1981; 294: 85-7.
17. Gaynor R, Irie R, Morton D, Herschman HR. S-100 protein is present in cultured human malignant melanoma. Nature 1980; 286: 400-1.
18. Pfeiffer SE, Kornblith PL, Cares HL, Seals J, Levine L. S-100 protein in human acoustic neurinomas. Brain Res 1972; 41: 187-93.
19. Egan M, Crocher J, Newman J, Collard M. Immunohistochemical localization of S-100 protein in skin tumours. Arch Pathol Lab Med 1986; 110: 765-7.
20. Van Hldik LJ, Jensen RA, Ehrenfried BA, Whetsell WO. Immunohistochemical localization of S-100β in human nervous system tumors by using monoclonal antibodies with specificity for the S-100β polypeptide. J Histochem Cytochem 1986; 34: 977-82.
21. Persson L, Hardemark HG, Gustafsson J, et al. S100 protein and neuron-specific enolase in cerebro-spinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987; 18: 911-8.
22. Sindic C, Chalon M, Cambiaso C, Laterre E, Masson P. Assessment of damage to the central nervous system by determination of S100 protein in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1982; 45: 1130-5.
23. Johnsson P, Lundqvist C, Lindgren A, Ferenez I, Alling C, Stahl H. Cerebral complications after cardiac surgery assessed by S-100 and NSH levels in blood. J Cardiothorac Vasc Anesth 1995; 9: 1-6.
24. Ingebrigtsen T, Romner B, Kongstad P, Langbakk B. Increased serum concentrations of protein S-100 after minor head injury: a biochemical serum marker with prognostic value. J Neurol Neurosurg Psychiatry 1995; 59: 103-4.
25. Wibe E, Hannisdal E, Paus E, Aamdal S. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma. Eur J Cancer 1992; 28: 1692-5.
26. Hau Bei Gou, Stoffel-Wagner B, Bierwirth T, Mezger J, Klingmuller D. Clinical significance of serum S100 in metastatic malignant melanoma. Eur J Cancer 1995; 31: 924-8.
27. American Joint Committee on Cancer. Manual for Staging of Cancer, 3rd edition. Philadelphia: JB Lippincott, 1988; 143-8.